Article Text

Download PDFPDF

An uncommon hip pain
Free
  1. Sandesh Madi,
  2. Vivek Pandey,
  3. Kiran Acharya,
  4. Vikash Kumar
  1. Department of Orthopaedics, Kasturba Medical College, Manipal, Karnataka, India
  1. Correspondence to Dr Sandesh Madi, sandesh.madi{at}gmail.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Description

A 55-year-old man with a medical history of hypertension and dyslipidaemia, presented to our Hip clinic with non-traumatic left hip pain of five months duration. The pain was  insidious in onset and gradually progressive. The pain  aggravated on , prolonged sitting or squatting, and relieved with rest. There was no history of any constitutional symptoms. The gait of the patient was essentially normal. There was tenderness over the anterior joint line and mild pain on flexion and internal rotation of the hip. There was no limb length discrepancy or wasting of the adjacent muscles. Distal neurovascular examination was normal.

A plain X-ray of the pelvis showed an ill-defined expansile lytic lesion involving the left superior pubic ramus with sclerotic margins and few internal septations (figure 1). Further CT and MRI scans defined the extent of the lesion (figure 2A,B,C and 3A,B,C). Through a Pfannenstiel incision, the lesion in the left superior pubic ramus was approached and a biopsy was undertaken. Histopathology and immunohistochemistry studies diagnosed the lesion as Plasmacytoma (figure 4). Myeloma profile (a panel of serological tests and bone marrow studies to evaluate patients with suspected multiple myeloma) was negative and bone scan revealed no other site involvement (table 1). With the diagnosis of Solitary Bone Plasmacytoma (SBP), the patient is currently undergoing Radiotherapy. A Radiotherapy regime: 2 Gy per day for 5 days is planned for 6 weeks using 3D Conformal Radiotherapy. Periodic serological investigations and immunofixation studies will be performed to determine the disappearance of serum M protein. Further, imaging studies (eg, fluorodeoxyglucose PET scans, for any regression of metabolic activity) will be used to monitor the response to treatment.

Figure 1

Plain X-ray of the pelvis showing an ill-defined expansile lytic lesion with sclerotic margins involving the left superior pubic ramus (red arrow). There is no evidence of any periosteal reaction. The rest of the bones are normal in density and alignment. Joint spaces and articular surfaces are normal.

Figure 2

CT scan showed lytic expansile lesion (3.9 cm × 2.9 cm) with sclerotic margin (A: coronal; B: sagittal; and C: axial sections).

Figure 3

MRI scan: An altered signal intensity lesion (red arrow) noted involvement of the left superior pubic ramus, roof and anterior column and anterior wall of acetabulum causing expansion of the bone with minimal postcontrast enhancement (A: coronal (T2W); B: sagittal (T2W); and C: axial (T1W) sections).

Figure 4

Histopathology (H&E stain; low power) section showing a tumour composed of sheets of plasma cells, scattered plasmablasts along with focal aggregates of lymphocytes interspersed with congested blood vessels (Inset: CD138-positive).

Table 1

Serological workup and Myeloma profile of the case

Localised plasma cell dyscrasia is divided into two types based on the location of the lesion: SBP (predominantly involving the axial skeleton) and ExtraMedullary Plasmacytoma (EMP). Both these lesions are differentiated fromMyeloma by lack of CRAB features (increased calcium, renal insufficiency, anaemia or multiple bone lesions). SBP is a rare plasma cell neoplasm that targets areas of the marrow with most active haematopoiesis; the order of frequency of the location in which they are typically found is the vertebrae (thoracic >lumbar/cervical), ribs, skull, pelvis, femur, clavicle and scapula.1 To our knowledge, SBP involving the pubic ramus and acetabulum has not been previously reported. The clinical presentation is usually pain that is believed to occur from the ongoing bone destruction. Sometimes it can also be an incidental finding in another radiological workup. In imaging studies, it appears as a lytic lesion and demands differentiation from other common lytic lesions specific to age and location. In case of clinical suspicion, the International Myeloma Working Group criteria (Myeloma profile + skeletal survey + histopathology) to diagnose SBP should be considered.2 In the index case, due to clinical presentation and endemic nature, tuberculosis was also considered in the differential diagnosis. Adverse prognostic factors include a lesion size of minimum 5 cm, age (>40 years), spine lesions, radiotherapy dose (<40 Gy), high M protein levels, existence of light chains and persistence of M protein after treatment.3 Further, a close follow-up is warranted to look out for local recurrence or conversion to a full blown Myeloma. SBP has a significantly higher risk (compared with EMP) for progression to Myeloma at a rate of 65%–84% in 10 years and 65%–100% in 15 years.3 Most series report overall survival (10-year rate) in the 49%–68% range.3

Learning points

  • This is perhaps the first case to be reported on Solitary Bone Plasmacytoma (SBP) arising from the superior pubic ramus and adjacent anterior acetabular wall.

  • Both radiologists as well as clinicians must be aware that SBP arising in the superior pubic ramus and acetabulum is an extremely rare cause of hip pain and needs to be included in the differential diagnosis for the lytic lesions in the pelvis.

References

View Abstract

Footnotes

  • Contributors SM: Drafting, data collection, revision. VP: Drafting , revision, final approval. KA: Drafting, revision, final approval. VK: Drafting, data collection, revision.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.